Literature DB >> 18216245

Formation of large coronary arteries by cardiac progenitor cells.

Jochen Tillmanns1, Marcello Rota, Toru Hosoda, Yu Misao, Grazia Esposito, Arantxa Gonzalez, Serena Vitale, Carola Parolin, Saori Yasuzawa-Amano, John Muraski, Antonella De Angelis, Nicole Lecapitaine, Robert W Siggins, Maria Loredo, Claudia Bearzi, Roberto Bolli, Konrad Urbanek, Annarosa Leri, Jan Kajstura, Piero Anversa.   

Abstract

Coronary artery disease is the most common cause of cardiac failure in the Western world, and to date there is no alternative to bypass surgery for severe coronary atherosclerosis. We report that c-kit-positive cardiac progenitor cells (CPCs) activated with insulin-like growth factor 1 and hepatocyte growth factor before their injection in proximity of the site of occlusion of the left coronary artery in rats, engrafted within the host myocardium forming temporary niches. Subsequently, CPCs divided and differentiated into endothelial cells and smooth muscle cells and, to a lesser extent, into cardiomyocytes. The acquisition of vascular lineages appeared to be mediated by the up-regulation of hypoxia-inducible factor 1alpha, which promoted the synthesis and secretion of stromal-derived factor 1 from hypoxic coronary vessels. Stromal-derived factor 1 was critical in the conversion of CPCs to the vascular fate. CPCs formed conductive and intermediate-sized coronary arteries together with resistance arterioles and capillaries. The new vessels were connected with the primary coronary circulation, and this increase in vascularization more than doubled myocardial blood flow in the infarcted myocardium. This beneficial effect, together with myocardial regeneration attenuated postinfarction dilated myopathy, reduced infarct size and improved function. In conclusion, locally delivered activated CPCs generate de novo coronary vasculature and may be implemented clinically for restoration of blood supply to the ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18216245      PMCID: PMC2234202          DOI: 10.1073/pnas.0706315105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Competing risks after coronary bypass surgery: the influence of death on reintervention.

Authors:  E H Blackstone; B W Lytle
Journal:  J Thorac Cardiovasc Surg       Date:  2000-06       Impact factor: 5.209

Review 2.  Adult stem cells for tissue repair - a new therapeutic concept?

Authors:  Martin Kørbling; Zeev Estrov
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

3.  Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction.

Authors:  Hidemasa Oh; Steven B Bradfute; Teresa D Gallardo; Teruya Nakamura; Vinciane Gaussin; Yuji Mishina; Jennifer Pocius; Lloyd H Michael; Richard R Behringer; Daniel J Garry; Mark L Entman; Michael D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

4.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

Review 5.  Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies.

Authors:  Douglas W Losordo; Stefanie Dimmeler
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

Review 6.  Anoikis.

Authors:  A J Valentijn; N Zouq; A P Gilmore
Journal:  Biochem Soc Trans       Date:  2004-06       Impact factor: 5.407

Review 7.  The failing heart--an engine out of fuel.

Authors:  Stefan Neubauer
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

8.  Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells.

Authors:  Alexandra Aicher; Christopher Heeschen; Christiane Mildner-Rihm; Carmen Urbich; Christian Ihling; Katja Technau-Ihling; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Nat Med       Date:  2003-10-12       Impact factor: 53.440

9.  Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.

Authors:  Ryo Fukuda; Kiichi Hirota; Fan Fan; Young Do Jung; Lee M Ellis; Gregg L Semenza
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

10.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

View more
  60 in total

1.  Early stages of in situ bladder regeneration in a rodent model.

Authors:  David Burmeister; Tamer Aboushwareb; Josh Tan; Kerry Link; Karl-Erik Andersson; George Christ
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

2.  Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.

Authors:  Georg Siegel; Petra Krause; Stefanie Wöhrle; Patrick Nowak; Miriam Ayturan; Torsten Kluba; Bernhard R Brehm; Birgid Neumeister; David Köhler; Peter Rosenberger; Lothar Just; Hinnak Northoff; Richard Schäfer
Journal:  Stem Cells Dev       Date:  2012-03-13       Impact factor: 3.272

3.  Ultrasound-induced microbubble destruction promotes targeted delivery of adipose-derived stem cells to improve hind-limb ischemia of diabetic mice.

Authors:  Ye Song; Xiaoyun Xie; Yuan Gao; Guojun Gu; Peijun Wang
Journal:  Am J Transl Res       Date:  2016-06-15       Impact factor: 4.060

4.  Factors Released from Embryonic Stem Cells Stimulate c-kit-FLK-1(+ve) Progenitor Cells and Enhance Neovascularization.

Authors:  Sumbul Fatma; Donald E Selby; Reetu D Singla; Dinender K Singla
Journal:  Antioxid Redox Signal       Date:  2010-07-28       Impact factor: 8.401

5.  Enhancing the potential of cardiac progenitor cells: pushing forward with Pim-1.

Authors:  Dominic P Del Re; Junichi Sadoshima
Journal:  Circ Res       Date:  2012-04-27       Impact factor: 17.367

Review 6.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

7.  Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis.

Authors:  Amankeldi A Salybekov; Akira T Kawaguchi; Haruchika Masuda; Kosit Vorateera; Chisa Okada; Takayuki Asahara
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

8.  Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase.

Authors:  Kimberlee M Fischer; Christopher T Cottage; Weitao Wu; Shabana Din; Natalie A Gude; Daniele Avitabile; Pearl Quijada; Brett L Collins; Jenna Fransioli; Mark A Sussman
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690

9.  De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells.

Authors:  Hua Zhang; James E Faber
Journal:  J Mol Cell Cardiol       Date:  2015-08-04       Impact factor: 5.000

10.  Stem cell therapy for heart failure.

Authors:  David Angert; Steven R Houser
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.